Summit Therapeutics (SMMT) Capital Expenditures (2017 - 2026)
Summit Therapeutics' Capital Expenditures came in at $909,000 for Q2 2026, up 271.0% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Capital Expenditures (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Summit Therapeutics reported Capital Expenditures of $1.39 million, up 181.2% year-over-year; for FY2025, it was $657,000, up 372.7% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $139,000 in FY2024 (+8.6%), $128,000 in FY2023 (-79.5%), $624,000 in FY2022 (+103.9%) and $306,000 in FY2021 (-27.3%).
- The Q2 2026 figure represents the highest quarterly Capital Expenditures in data going back to Q4 2018.
- Year-over-year, Capital Expenditures increased in three of the last four quarters, with growth averaging 147.5%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2022 (growth of 825.6%), and the weakest in Q2 2023 (a decline of 93.2%).
- Business Quant data shows SMMT's Capital Expenditures at $245,000 (Q1 2026), $164,000 (Q4 2025) and $71,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Summit Therapeutics | 13.28 Bn | 11.04 Bn | - | 909,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 909,000.00 |
| Mar 31, 2026 | 245,000.00 |
| Dec 31, 2025 | 164,000.00 |
| Sep 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 422,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 53,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2022 | -20,000.00 |
| Jun 30, 2022 | 293,000.00 |
| Mar 31, 2022 | 361,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | 151,000.00 |
API Access
Summit Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();